Form D · Other

Invictus MD Strategies Corp.

White Rock, A1 · CIK 0001737647

Offering snapshot reported Apr 17, 2018 · SEC filing

Reported sold
$6.51M
Offering amount: $12.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 14, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2018Initial$6,506,728No comparison1SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-310328
Purch & Sale Agmt to acquire all outstndng shs of Gene-Etics Strains Co. for $2,500,000USD cash & 2,631,141 cmn shs of issuer at closing & 1,973,355 shares 180 days post close & 1,973,355 on later of 240 days post close or 1/2/2019 @$1.94 per sh
Purch & Sale Agmt to acquire all outstndng shs of Gene-Etics Strains Co. for $2,500,000USD cash & 2,631,141 cmn shs of issuer at closing & 1,973,355 shares 180 days post close & 1,973,355 on later of 240 days post close or 1/2/2019 @$1.94 per sh

Source: Form D, filed Apr 17, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aaron Bowden Director
Trevor Dixon Director, Executive
Brenda Dixon Executive
Dylan Easterbrook Executive
Josef W Hocher Director
Dan Kriznic Director, Executive
George Kveton Director
Paul Sparkes Director

Issuer details

Industry: Other (See others in industry)

Address:
Hillcrest Po P.O. Box 71567
White Rock, A1, V4B 5J5